BioCentury
ARTICLE | Company News

BioDelivery, Accentia deal

September 13, 2004 7:00 AM UTC

Accentia will pay BDSI $2.5 million to reduce its royalty owed to BDSI by 50% under an April deal to develop topical encochleated amphotericin B to treat chronic rhinosinusitis. The original royalty r...